HCA Healthcare HCA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$183.88M (4 inflow days, 16 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 48.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 2.83% to 2.30% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Capital Research | Mutual Fund | 2026/Q3 | +794,171 | 2.2% |
| Deka Investment GmbH | Mutual Fund | 2026/Q3 | +326,441 | 0.2% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +243,474 | 0.1% |
| Amundi Asset Management | Mutual Fund | 2026/Q3 | +218,457 | 0.3% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +190,129 | 0.6% |
| Life Cycle Investment Partners Limited | Mutual Fund | 2026/Q3 | +158,519 | 0.5% |
| Russell Investment Management, LLC | Mutual Fund | 2026/Q3 | +122,894 | 0.3% |
| Employees Retirement System of Texas | Government Pension Fund | 2026/Q3 | +119,000 | 0.1% |
| Crake Asset Management LLP | Hedge Fund | 2026/Q3 | +1,151,792 | 0.6% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +799,761 | 2.3% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +756,768 | 0.6% |
| Metropolis Capital Limited | Mutual Fund | 2026/Q3 | +602,264 | 0.4% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +515,905 | 0.9% |
| Consulta Ltd. | Hedge Fund | 2026/Q3 | +400,000 | 0.2% |
| Darsana Capital Partners LP | Hedge Fund | 2026/Q3 | +350,000 | 0.5% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | Erica Rossitto | Senior VP & Chief Nurse Executive | Derivative Exercise and Sale | -10,101 | $505.81 | 13,426 |
| 5 Nov 2026 | Erica Rossitto | Senior VP & Chief Nurse Executive | Derivative Exercise and Retained | +3,019 | $81.96 | 13,426 |
| 5 Nov 2026 | Jon Foster | Chief Operating Officer | Open Market Disposition | -31,713 | $514.07 | 178,374 |
| 3 Nov 2026 | Jon Foster | Chief Operating Officer | Other Disposition | -571 | $503.53 | 178,374 |
| 3 Nov 2026 | Jon Foster | Chief Operating Officer | Derivative Exercise and Sale | -35,880 | $510.70 | 178,374 |
| 3 Nov 2026 | Hercules Holding Ii, LLC | Other Acquisition | +555,500 | $503.53 | 32,282,889 | |
| 3 Nov 2026 | Hercules Holding Ii, LLC | Other Disposition | -555,500 | $503.53 | 32,282,889 | |
| 3 Nov 2026 | Michael Schlosser | Executive Vice President & Chief Clinical Officer | Open Market Disposition | -1,200 | $494.65 | 8,394 |
| 1 Nov 2026 | Michael Marks | Chief Financial Officer | Derivative Exercise and Sale | -4,371 | $473.19 | 74,332 |
| 29 Oct 2026 | Michael Marks | Chief Financial Officer | Derivative Exercise and Retained | +214 | $81.96 | 74,332 |
| 28 Oct 2026 | Michael Schlosser | Executive Vice President & Chief Clinical Officer | Derivative Exercise and Sale | -2,455 | $478.08 | 9,594 |
| 28 Oct 2026 | Michael Schlosser | Executive Vice President & Chief Clinical Officer | Other Derivative Acquisition | +2,797 | $478.08 | 2,797 |
| 28 Oct 2026 | Michael Schlosser | Executive Vice President & Chief Clinical Officer | Derivative Exercise and Retained | +2,473 | $81.96 | 9,594 |
| 31 Aug 2026 | Michael Schlosser | Executive Vice President & Chief Clinical Officer | Initial Statement of Beneficial | +0 | – | 40,712 |
| 25 Aug 2026 | Michael McAlevey | Executive VP and Chief Legal & Administrative Officer | Other Disposition | -7,769 | $429.00 | 10,990 |
| 6 May 2026 | Michael Marks | Chief Financial Officer | Other Acquisition | +3,336 | – | 73,076 |
| 6 May 2026 | Michael Marks | Chief Financial Officer | Other Disposition | -3,336 | – | 73,076 |
| 27 Apr 2026 | John Chidsey | Independent Director | Other Acquisition | +809 | – | 809 |
| 27 Apr 2026 | Michael Michelson | Independent Director | Other Acquisition | +925 | – | 12,576 |
| 27 Apr 2026 | Nancy-Ann DeParle | Independent Director | Other Acquisition | +509 | – | 509 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 4,800,941 | 2.3% | 3.3 |
| 15 Oct 2026 | 4,906,014 | 2.3% | 4.6 |
| 30 Sep 2026 | 4,884,718 | 2.3% | 3.1 |
| 15 Sep 2026 | 6,479,985 | 3.0% | 4.5 |
| 31 Aug 2026 | 6,135,558 | 2.8% | 4.9 |
| 14 Aug 2026 | 6,127,018 | 2.8% | 5.6 |
No comments yet — be the first to weigh in on HCA.
Sign in to join the discussion.